Cargando…

Editorial: The Role of Epigenetic Modifications in Cancer Progression

Detalles Bibliográficos
Autores principales:	Fujimura, Atsushi, Pei, Hailong, Zhang, Hongquan, Sladitschek, Hanna Lucie, Chang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820891/ https://www.ncbi.nlm.nih.gov/pubmed/33489924 http://dx.doi.org/10.3389/fonc.2020.617178

Ejemplares similares

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application
por: Lin, Hon-Yi, et al.
Publicado: (2023)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Editorial: The role of iron in cancer progression
por: Hamaï, Ahmed, et al.
Publicado: (2022)

Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer
por: Xie, Junyuan, et al.
Publicado: (2023)

Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
por: Brunetti, Bryce, et al.
Publicado: (2023)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression
por: Yang, Yongyong, et al.
Publicado: (2023)

Editorial: The Role of Platelets in Cancer Progression and Malignancy
por: Schlesinger, Martin, et al.
Publicado: (2021)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
por: Yang, Qingfan, et al.
Publicado: (2022)

Editorial: The role of transcription factors, stem cell markers and epigenetics contributing to chemoresistance in brain cancers
por: Castresana, Javier S., et al.
Publicado: (2023)

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance
por: Thakur, Abhimanyu, et al.
Publicado: (2023)

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers
por: Wang, Lihui, et al.
Publicado: (2022)

An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
por: Zhao, Yuhao, et al.
Publicado: (2022)

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis
por: Li, Yonghui, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Epigenetics and cellular plasticity in glioblastoma
por: Lo, Hui-Wen, et al.
Publicado: (2023)

Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers
por: Gimple, Ryan C., et al.
Publicado: (2023)

Editorial: The role of STAT3 signaling pathway in tumor progression
por: Chang, Nan-Shan, et al.
Publicado: (2023)

Editorial: The role of epigenetic modification in MDSC differentiation and function
por: Tian, Xinyu, et al.
Publicado: (2023)

Editorial: Epigenetics and molecular genetics of rare tumors
por: Tognon, Mauro, et al.
Publicado: (2022)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II
por: Lu, Qisi, et al.
Publicado: (2023)

Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Lu, Maoqing, et al.
Publicado: (2021)

Editorial: Role of Epigenetic Modifications on Diet-Induced Metabolic Diseases
por: Vinciguerra, Manlio, et al.
Publicado: (2020)

Editorial: 365 days of progress in cancer genetics
por: Ratajska, Magdalena, et al.
Publicado: (2023)

Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia
por: Dhall, Abhinav, et al.
Publicado: (2019)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

The Roles of Base Modifications in Kidney Cancer
por: Feng, Chunyue, et al.
Publicado: (2020)

Editorial: Role of epigenetic regulators in the initiation, progression, and metastasis of cancer
por: Chatterjee, Aniruddha, et al.
Publicado: (2022)

Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles
por: Aishanjiang, Kedeerya, et al.
Publicado: (2021)

Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression
por: Zhao, Yue, et al.
Publicado: (2023)

Editorial: Molecular mechanisms in breast cancer progression and metastasis
por: Fedele, Monica, et al.
Publicado: (2022)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

Epigenetic Therapy in Lung Cancer – Role of microRNAs
por: Rothschild, Sacha I.
Publicado: (2013)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Epigenetic modification of m(6)A regulator proteins in cancer
por: Wang, Yumin, et al.
Publicado: (2023)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
por: Li, Qinghai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nbj2coi5mbft0mh47ahppoh5ir